STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 68 filers reported holding STOKE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,308,872 | -60.6% | 586,008 | +6.2% | 0.00% | – |
| Q2 2023 | $5,864,380 | +67.0% | 551,682 | +30.8% | 0.00% | – |
| Q1 2023 | $3,512,161 | -54.0% | 421,628 | -49.0% | 0.00% | – |
| Q4 2022 | $7,637,806 | +44.5% | 827,498 | +101.1% | 0.00% | – |
| Q3 2022 | $5,284,000 | +4.7% | 411,490 | +7.7% | 0.00% | – |
| Q2 2022 | $5,048,000 | -74.9% | 382,106 | -59.9% | 0.00% | -100.0% |
| Q1 2022 | $20,082,000 | +5.1% | 954,025 | +19.7% | 0.00% | 0.0% |
| Q4 2021 | $19,116,000 | -17.8% | 796,852 | -12.9% | 0.00% | 0.0% |
| Q3 2021 | $23,269,000 | -23.6% | 914,671 | +1.1% | 0.00% | -50.0% |
| Q2 2021 | $30,457,000 | +4.9% | 904,836 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $29,025,000 | +8.0% | 747,288 | +72.1% | 0.00% | 0.0% |
| Q4 2020 | $26,884,000 | +249.9% | 434,108 | +89.2% | 0.00% | +100.0% |
| Q3 2020 | $7,683,000 | +20.7% | 229,412 | -14.1% | 0.00% | – |
| Q2 2020 | $6,366,000 | -5.5% | 267,139 | -9.2% | 0.00% | -100.0% |
| Q1 2020 | $6,739,000 | +40.2% | 294,281 | +73.4% | 0.00% | – |
| Q4 2019 | $4,807,000 | +60.9% | 169,744 | +22.1% | 0.00% | – |
| Q3 2019 | $2,987,000 | – | 138,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $1,062,825,000 | 82.06% |
| RTW INVESTMENTS, LP | 3,544,248 | $219,495,000 | 3.68% |
| Cormorant Asset Management, LP | 1,437,807 | $89,043,000 | 2.12% |
| Redmile Group, LLC | 2,686,234 | $166,358,000 | 2.01% |
| ACUTA CAPITAL PARTNERS, LLC | 92,500 | $5,729,000 | 1.56% |
| Pinz Capital Management, LP | 34,200 | $2,118,000 | 0.96% |
| Birchview Capital, LP | 20,000 | $1,239,000 | 0.71% |
| HighVista Strategies LLC | 17,668 | $1,094,000 | 0.70% |
| GILDER GAGNON HOWE & CO LLC | 1,470,841 | $91,089,000 | 0.45% |
| Perceptive Advisors | 671,978 | $41,616,000 | 0.45% |